Longwood Capital Partners »

Lb Pharmaceuticals shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Lb Pharmaceuticals shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $474k 30k 15.79

More positions owned by Longwood Capital Partners

Ocular Therapeutix (OCUL)
Cidara Therapeutics Com New (CDTX)
Tourmaline Bio (TRML)
Aadi Bioscience (WHWK)
Insmed Com Par $.01 (INSM)
Bright Minds Biosciences Com New (DRUG)
Argen Se - Sponsored Adr (ARGX)
Amylyx Pharmaceuticals (AMLX)
Terns Pharmaceuticals (TERN)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Compass Therapeutics (CMPX)
Praxis Precision Medicines I (PRAX)
Surrozen Com New (SRZN)
Ascendis Pha- Sponsored Adr (ASND)
Krystal Biotech (KRYS)

View all positions for Longwood Capital Partners

Top funds holding Lb Pharmaceuticals

Deep Track Capital
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Jpmorgan Chase & Co
BlackRock
Balyasny Asset Management
Vivo Capital
Jennison Associates
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management
Soleus Capital Management

View all funds holding Lb Pharmaceuticals